Skip to main content

Table 1 Liver function thresholds to establish clinically meaningful deterioration after TACE in a real-world setting (primary analysis)

From: Liver function changes after transarterial chemoembolization in US hepatocellular carcinoma patients: the LiverT study

Parameter

Deterioration threshold (change from baseline)

Serum total bilirubin

Increase of ≥ 50%

Serum albumin

Decrease by ≥ 0.3 g/dL

AST

Increase of > 25%

ALT

Increase of > 25%

INR

Increase of ≥ 25%

  1. ALT alanine transaminase, AST aspartate transaminase, INR international normalized ratio, TACE transarterial chemoembolization
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us